An Observational, Qualitative Study Assessing Eye Drop Administration
A Prospective, Observational, Consecutive, Qualitative, Multicenter Study Assessing Eye Drop Administration
Sponsor: Ocular Therapeutix, Inc.
This observational or N/A phase trial investigates Ocular Injury and is currently ongoing. Ocular Therapeutix, Inc. leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
5 versions recorded-
Oct 2024 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2022 — Jul 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2022 — Sep 2022 [monthly]
Not Yet Recruiting
First recorded
Apr 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ocular Therapeutix, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Sioux Falls, United States